Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD) : an open-label phase II randomised trial (AIO/IAG-KHT trial 1108)

Klinghammer, K.; Gauler, T.; Dietz, A.; Gruenwald, V.; Stoehlmacher, J.; Knipping, S.; Schroeder, M.; Guntinas-Lichius, O.; Frickhofen, N.; Lindeman, H. -W.; Fietkau, R.; Haxel, B.; Grosse-Thie, C.; Maschmeyer, G.; Zipfel, M.; Martus, P.; Knoedler, M.; Keilholz, U.

Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD) : an open-label phase II randomised trial (AIO/IAG-KHT trial 1108)

Autor(en):

Klinghammer, K.; Gauler, T.; Dietz, A.; Gruenwald, V.; Stoehlmacher, J.; Knipping, S.; Schroeder, M.; Guntinas-Lichius, O.; Frickhofen, N.; Lindeman, H. -W.; Fietkau, R.; Haxel, B.; Grosse-Thie, C.; Maschmeyer, G.; Zipfel, M.; Martus, P.; Knoedler, M.; Keilholz, U.

Tübinger Autor(en):

Martus, Peter

Erschienen in:

European Journal of Cancer (2019), Bd. 122, S. 53-60

Verlagsangabe:

Elsevier Sci Ltd

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/j.ejca.2019.08.018

ISSN:

1879-0852